The Artificial Lung Devices Market is expanding steadily as increasing prevalence of acute respiratory distress syndrome, chronic lung diseases, and COVID-19-related lung failure drives demand for extracorporeal membrane oxygenation and artificial lung systems. Growing need for bridge-to-transplant and bridge-to-recovery solutions, along with technological miniaturization, is significantly strengthening market growth.As per WiseGuy Reports analysis, the Artificial Lung Devices Market was valued at 2,100 USD Million in 2024. The Artificial Lung Devices Market is expected to grow from 2,300 USD Million in 2025 to 4,500 USD Million by 2035. The Artificial Lung Devices Market CAGR (growth rate) is expected to be around 7.1% during the forecast period (2025 - 2035).
Read More Detailed Insights:
www.wiseguyreports.com/reports/artificial-lung-devices-market
Key growth drivers include increasing incidence of acute respiratory failure and COPD, rising adoption of ambulatory and portable ECMO devices for long-term support, and growing investment in pumpless and low-resistance artificial lung technologies. Advances in biocompatible coatings, oxygenator membranes, and wearable configurations are further propelling market expansion.
Regionally, North America leads the market due to advanced ECMO centers and strong reimbursement for respiratory support. Europe follows with established intensive care infrastructure, while the Asia-Pacific region is emerging rapidly as critical care capabilities expand across China and Japan.
Related Reports:
High-Density HD Cell Banking Market
Heterozygous Familial Hypercholesterolemia HEFH Management Market
Clinical Chemistry Enzyme Market
Intermittent Pneumatic Compression IPC Device Market
Neurovascular Guidewire Market
Imaging Tracer Market
Bone Cutting Technology Market
Teeth Desensitizer Market
Genomic Urine Testing Market